Autonomix Medical, Inc. (NASDAQ:AMIX – Get Free Report) saw a large increase in short interest during the month of May. As of May 29th, there was short interest totaling 646,074 shares, an increase of 230.7% from the May 14th total of 195,368 shares. Based on an average daily volume of 4,028,480 shares, the days-to-cover ratio is currently 0.2 days. Currently, 10.0% of the shares of the stock are sold short.
Autonomix Medical Stock Performance
Shares of NASDAQ:AMIX traded down $0.01 during trading hours on Thursday, reaching $0.37. The stock had a trading volume of 8,566 shares, compared to its average volume of 939,922. Autonomix Medical has a 1 year low of $0.20 and a 1 year high of $2.64. The stock has a market capitalization of $2.57 million, a price-to-earnings ratio of -0.10 and a beta of -1.43. The firm’s 50 day moving average is $0.38 and its 200-day moving average is $0.48.
Analyst Upgrades and Downgrades
A number of research firms have commented on AMIX. Zacks Research upgraded shares of Autonomix Medical to a “hold” rating in a report on Tuesday, June 2nd. Maxim Group lowered their price target on Autonomix Medical from $5.00 to $2.00 and set a “buy” rating for the company in a research report on Tuesday, February 17th. Finally, Weiss Ratings downgraded Autonomix Medical from a “sell (e+)” rating to a “sell (e)” rating in a report on Wednesday, June 3rd. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $2.00.
About Autonomix Medical
Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Read More
- Five stocks we like better than Autonomix Medical
- 3 Stocks Cashing In on AI While Everyone Watches NVIDIA
- 2 Ways to Play the QXO/TopBuild Deal
- Wolfspeed Ditches EV Woes for High-Margin Defense Jets
- Casey’s Is Looking Like a Hot Buy as Growth, Buybacks, and Guidance Align
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.
